Thank you PTLD Champions for contributing your remarkable stories. We firmly believe that the most promising path to finding new therapies comes when those affected by a serious unmet medical need lend their voices to the process. Our company was named and founded for Atara Ciechanover, who, unfortunately, passed away after her battle with ovarian cancer. Taking inspiration from her experience, our mission has been to transform the lives of patients with serious diseases. We can only accomplish this mission by connecting with champions like you to better understand your journeys.
PTLD is like 90% of rare diseases; there is no FDA approved therapy for treatment. The only way to understand the impact of this “orphan” disease is to hear from the experts like you about how PTLD affects your lives. We are grateful that you lent your expertise to help others understand the arduous journey for someone who has already faced a life-threatening condition requiring a transplant then has to fight PTLD. Your willingness to share your story will serve to help others understand the patient journey and the unmet medical need for new innovative PTLD treatments. We are also acutely aware that many patients are not able to overcome PTLD. Your willingness to participate in this project honors their memory and provides hope to current and future PTLD patients.
We are so grateful that you graciously opened your lives and your homes to us. Your stories inspire us at Atara to work even harder to develop novel T-cell immunotherapies for patients living with cancer, autoimmune and viral diseases. They also fuel our sense of urgency because patients can’t wait.
With sincere appreciation for inspiring us and for being our partners in fulfilling our mission.
– Your Atarian Family